Question 1

What is Rafael de la Torre Fornell?

Accepted Answer

Rafael de la Torre Fornell is a Person.

Question 2

How often does Rafael de la Torre Fornell appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Rafael de la Torre Fornell first tracked by Ergen?

Accepted Answer

First tracked on Jun 10, 2026.

Question 4

When was Rafael de la Torre Fornell last mentioned in news?

Accepted Answer

Last active on Jun 10, 2026.

Question 5

What is Rafael de la Torre Fornell's current news sentiment?

Accepted Answer

Aggregate sentiment score: 50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Rafael de la Torre Fornell in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Rafael de la Torre Fornell?

Accepted Answer

CONNECTA_Therapeutics Initiates CTH120 Phase IIa Trial (Jun 10, 2026, 6 articles).

Question 8

How did the "CONNECTA_Therapeutics Initiates CTH120 Phase IIa Trial" event impact Rafael de la Torre Fornell?

Accepted Answer

Rafael de la Torre Fornell>>>, Principal Investigator at Hospital del Mar Research Institute>>>, emphasized the unmet medical need in Fragile X syndrome>>> and the potential of the CTH120>>> trial.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.